FluxMPS™ Leibovitz's L-15 Medium w/o Phenol Red: 2X Liquid
FluxMPS™ DCP-LL15-R2X is a Microfluidics Suitable, quadruple-stage ultra-filtered Leibovitz's L-15 2X formulation without phenol red, engineered for primary cells, in vivo imaging, and CO2-free culture on microfluidic and organ-on-a-chip (OoC) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. CO2-free by design — uses D-galactose and high amino acid buffering for atmospheric pH maintenance.
- CO2-free by design: D-galactose energy source + high amino acid buffering — no gas supplementation required
- Quadruple-stage filtration system (0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II — Polish)
- Endotoxin release specification: < 0.05 EU/mL (LAL assay, USP <85>)
- Formulation: 1.8 g/L D-Galactose (carbon source), L-Glutamine, Sodium Pyruvate — phenol red-free, 2X concentrated
- Ultrapure Type 1 water (18.2 MΩ·cm) processing; ISO 13485:2016 quality management system; ISO Class 5 aseptic fill
- Manufactured and released under per-lot QC with a full Certificate of Analysis available on request
- Media familyLeibovitz's L-15 2X
- Carbon source (D-Galactose)1800 mg/L (1.8 g/L)
- Formulation[+] L-Glutamine, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Phenol Red
- AppearancePale yellow colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)620–680 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm–filtered Leibovitz's passes subvisible particulates and endotoxin fragments that interfere with CO2-free pH maintenance and live imaging clarity. FluxMPS™ is built to reduce these failure modes.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 particulate compliance. Low-particulate L-15 for CO2-free chip loading.
CO2-free by design formulation
Leibovitz's L-15 uses D-galactose (not glucose) as the primary carbon source and high amino acid concentrations for CO2-free pH buffering. This is a 2X concentrated formulation.
Ultrapure-grade water
18.2 MΩ·cm processing water controls trace metals and organic carbon during manufacture.
Low endotoxin release specification
< 0.05 EU/mL release specification — relevant where endotoxin can influence TLR4-mediated activation in primary cells.
CO2-free design
D-galactose + high amino acid buffering supports pH stability in atmospheric conditions — no CO2 incubator required.
Customization on demand
pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages, run as two dedicated prefilter + final-filter pairs, reaching a 0.04 µm final pore size under ISO Class 5 aseptic conditions.
-
1
0.1 µm Prefiltration I
Removes large particulate, cell debris, and protein aggregates; protects the first 0.04 µm final filter cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass a standard 0.22 µm filter.
-
3
0.1 µm Prefiltration II
Second dedicated 0.1 µm prefilter, protecting the second 0.04 µm final filter cartridge; contributes to mycoplasma-retentive filtration.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; ISO Class 5 aseptic fill & finish.
Performance vs. conventional media
© Diagnocine® — DCP-LL15-R2X
CO2-free live imaging and primary cell applications
FluxMPS™ DCP-LL15-R2X — Leibovitz's L-15 2X without phenol red — delivers 0.04 µm filtered purity for primary cells and related microfluidic applications.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) MPS Grade variant of this formulation is available on request for automated bioreactors and robotics — see the Grade note in the filtration section above.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion systems
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Open-Stage & CO2-Free Microscopy
L-15 with galactose maintains pH without CO2 — a standard base for prolonged live-cell confocal, TIRF, light-sheet, and spinning disk imaging on open-stage microscopes. Removal of phenol red reduces background fluorescence for these applications.
Primary Cell Dissociation & Transport
CO2-free L-15 is used as a dissociation and transport medium for primary cells, tissue pieces, and organoids outside the incubator.
OoC Loading & Priming
CO2-independent L-15 enables chip loading, priming, and cell seeding outside incubators without pH drift during chip assembly steps.
In Vivo Imaging & Intravital Microscopy
L-15 is used as a superfusion medium for intravital microscopy, supporting pH stability in open tissue preparations without CO2 during surgical and imaging procedures.
CO2-Free Metabolic Studies
The galactose-based energy source supports metabolic studies without CO2 interference; galactose forces oxidative metabolism in metabolically flexible cells.
Acute Brain Slice & Neuron Imaging
CO2-free L-15 supports neuronal viability in acute brain slice preparations and dissociated neuron imaging without requiring carbogen (95% O2/5% CO2) gassing.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | 1.8 g/L D-Galactose (carbon source); [+] L-Glutamine, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Phenol Red |
| Appearance | Pale yellow colored, clear solution |
| Carbon source | D-Galactose: 1800 mg/L (1.8 g/L) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 620–680 mOsm/kg H2O |
| Total ingredients | 34 components across 4 categories |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | CO2-independent by design — galactose and high amino acid buffering maintain pH without gas supplementation. |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Leibovitz's L-15 2X: 34 ingredients released per lot with CAS numbers for full raw-material traceability. Leibovitz's L-15 uses D-galactose (not glucose) as the primary carbon source and high amino acid concentrations for CO2-free pH buffering. This is a 2X concentrated formulation.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 370.000 |
| Magnesium chloride hexahydrate | 7791-18-6 | 400.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 195.440 |
| Potassium chloride | 7447-40-7 | 800.000 |
| Potassium phosphate monobasic | 7778-77-0 | 120.000 |
| Sodium chloride | 7647-14-5 | 16000.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 380.240 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Alanine | 56-41-7 | 450.000 |
| Glycine | 56-40-6 | 400.000 |
| L-Arginine (free base) | 74-79-3 | 1000.000 |
| L-Asparagine | 70-47-3 | 500.000 |
| L-Cysteine (free base) | 52-90-4 | 240.000 |
| L-Glutamine | 56-85-9 | 600.000 |
| L-Histidine (free base) | 71-00-1 | 500.000 |
| L-Isoleucine | 73-32-5 | 500.000 |
| L-Leucine | 61-90-5 | 250.000 |
| L-Lysine hydrochloride | 657-27-2 | 188.000 |
| L-Methionine | 63-68-3 | 150.000 |
| L-Phenylalanine | 63-91-2 | 250.000 |
| L-Serine | 56-45-1 | 400.000 |
| L-Threonine | 72-19-5 | 600.000 |
| L-Tryptophan | 73-22-3 | 40.000 |
| L-Tyrosine disodium salt | 69847-45-6 | 552.320 |
| L-Valine | 72-18-4 | 200.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 2.000 |
| D-Ca-Pantothenate | 137-08-6 | 2.000 |
| Folic acid | 59-30-3 | 2.000 |
| Nicotinamide | 98-92-0 | 2.000 |
| Pyridoxine hydrochloride | 58-56-0 | 2.000 |
| Riboflavin-5-phosphate sodium salt | 130-40-5 | 0.200 |
| Thiamine hydrochloride | 67-03-8 | 2.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 4.000 |
| D-Galactose | 59-23-4 | 1800.000 |
| Sodium Pyruvate | 113-24-6 | 1100.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm processing water controls trace metals and organic carbon.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay; assay sensitivity 0.005 EU/mL; batch release specification < 0.05 EU/mL.
Particulate — USP <788> Method 1
NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm); light obscuration particle count.
Osmolality — USP <785>
Target: 620–680 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-LL15-R2X compares
FluxMPS™ DCP-LL15-R2X vs. conventional 0.22 µm–filtered Leibovitz's and DMEM/RPMI formulations. Rows without a sourced comparison figure are shown as "Not specified" rather than estimated.
| Parameter | DCP-LL15-R2X (FluxMPS™) | Conventional Leibovitz's L-15 (0.22 µm filtered) |
Standard DMEM/RPMI (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| L-15 2X without phenol red | check_circle Yes | Not specified | Not specified |
| Final filtration pore size | 0.04 µm | Not specified | Not specified |
| Number of filtration stages | 4 (Quadruple) | Not specified | Not specified |
| Mycoplasma barrier filtration | check_circle Yes (0.1 µm) | Not specified | Not specified |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate compliance | check_circle Yes | Not specified | Not specified |
| Water quality | Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Manufacturing QMS | ISO 13485:2016 | Not specified | Not specified |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable | Not specified | Not specified |
| Custom formulation | check_circle Yes | Not specified | Not specified |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-LL15-R2X — Leibovitz's L-15 2X without phenol red.
Supporting literature
Key publications supporting Leibovitz's L-15 2X in CO2-free live-cell imaging, primary cell culture, and microfluidic/OoC applications.
- Leibovitz A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am J Hyg. 1963;78:173–180. doi:10.1093/oxfordjournals.aje.a120329
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
